VRDN Viridian Therapeutics, Inc.De

$16.62 -0.48%

Healthcare · Pharmaceutical Preparations

Viridian Therapeutics, Inc.De (VRDN) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.7 billion. Shares last traded at $16.62, 52.5% below their 52-week high. Over the past year the stock is up 12.0%. Net profit margin is -483.6%, below the peer median of -0.1%. Revenue grew 23359.9% year over year.

Market Cap

$1.7B

Shares Out

103.1M

EPS (TTM)

$-9.56

P/E Ratio

—

P/S Ratio

24.18

P/B Ratio

2.69

Dividend / Share

—

Dividend Yield

—

52-Week High

$35.00

52-Week Low

$12.00

Volume

90,548

Avg Vol (3m)

150,608.159

Performance

+3.10%

+4.01%

-40.30%

-49.41%

YTD

-45.81%

+11.99%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

50.79

SMA (50)

$15.87

SMA (200)

$24.16

Price vs SMA50

+4.75%

Price vs SMA200

-31.20%

ATR (14)

$0.97

Financials

Revenue

$71M

Net Income

$-343M

Gross Margin

—

Operating Margin

-512.9%

Net Margin

-483.6%

Return on Equity

-53.9%

Return on Assets

-43.4%

Current Ratio

15.15

Debt / Equity

0.03

Revenue Growth (YoY)

+23359.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2024	$-2.98	2024-11-12
Q2 2024	$-1.82	2024-08-08
Q1 2024	$-0.79	2024-05-08
FY 2023	$-5.31	2024-02-27
Q3 2024	$-3.97	2024-11-12
Q2 2024	$-2.88	2024-08-08

Full earnings history →

Pharmaceutical Preparations peers

VRDN vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

24.18 / 3.54 med

+583% premium

Net margin vs peers

-483.6% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.